Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00310362 · ClinicalTrials.gov registry record · NA
Use of Telehealth In-home Messaging to Improve GI (Gastrointestinal) Endoscopy Completion Rates
A NA study, sponsored by VA Office of Research and Development.
- Completed
- Registry status
- NA
- Development phase
- 3,610
- Enrollment target
NCT00310362: Completed NA study, sponsored by VA Office of Research and Development.
NCT00310362 is a NA study that has completed, run by VA Office of Research and Development. The registered enrollment target is 3,610 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00310362, a NA study, has completed, sponsored by VA Office of Research and Development.
- COMPLETED
- Registry status
- NA
- Development phase
- 3,610 participants
- Enrollment target
Study Summary
Low endoscopy completion rates are a major problem in the VA, causing delay or failure to receive essential care, increased clinic wait times, lost capacity, increased costs, thus limiting endoscopic screening for colorectal cancer. This study tests whether an Interactive Voice Response (IVR) messaging system is equally effective in promoting the completion of flexible sigmoidoscopy and colonoscopy as usual clinical care practices that include phone calls from nurses to patients prior to preparation and procedures. Previous studies have examined the role of scheduling facilitation or patient adherence on endoscopy completion and the use of IVR technology to enhance patient adherence in other medical contexts. This is the first study, however, to evaluate the use of IVR for endoscopy completion and the first to compare it to the effectiveness of phone calls from nurses prior to an endoscopy appointment.
Interventions
- BEHAVIORAL Use of Interactive Voice Response (IVR) system to improve adherence to GI appointments and prep procedures
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3,610 participants |
| Start Date | 2007-07 |
| Est. Completion | 2009-02 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00310362
The ClinicalTrials.gov registry entry for NCT00310362 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 3,610 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is VA Office of Research and Development, which has 1,668 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Use of Interactive Voice Response (IVR) system to improve adherence to GI appointments and prep procedures is the first listed.
NCT00310362 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00310362 about?
NCT00310362 is a clinical study titled "Use of Telehealth In-home Messaging to Improve GI (Gastrointestinal) Endoscopy Completion Rates". Low endoscopy completion rates are a major problem in the VA, causing delay or failure to receive essential care, increased clinic wait times, lost capacity, increased costs, thus limiting endoscopic screening for colorectal cancer. This study tests whether an Interactive Voice Response (IVR) messag...
What is the current status of trial NCT00310362?
This trial is currently completed. It is a NA study. The enrollment target is 3,610 participants. The study started on 2007-07. Estimated completion is 2009-02.
What interventions are being tested in trial NCT00310362?
The interventions under investigation include: Use of Interactive Voice Response (IVR) system to improve adherence to GI appointments and prep procedures (BEHAVIORAL).
Who is sponsoring clinical trial NCT00310362?
This trial is sponsored by VA Office of Research and Development, which has 1,668 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.